Open AccessIliac Venous Stenting
Author(s) -
Robert D. McBane,
Robert J. Leadley,
Sangita M. Baxi,
Krzysztof Karnicki,
Waldemar E. Wysokiński
Publication year - 2007
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.107.158691
Subject(s) - aspirin , clopidogrel , medicine , thrombus , platelet , p2y12 , platelet activation , venous thrombosis , stent , thrombosis , anesthesia , pharmacology
The clinical use of venous stents is increasing dramatically. Although antiplatelet agents are required for arterial stent patency, optimal thrombo-prophylaxis after venous stenting remains undefined. To address this issue, PD0348292, a direct Factor Xa inhibitor, was compared with antiplatelet therapy in a porcine venous stent model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom